Viewing Study NCT00416351


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-05-19 @ 1:54 AM
Study NCT ID: NCT00416351
Status: COMPLETED
Last Update Posted: 2022-05-17
First Post: 2006-12-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 06-065
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None OTHER View
None OTHER View